A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...
1don MSN
Immune sabotage: How a Vitamin A byproduct compromises the body's normal anti-cancer response
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...
Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...
Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...
Researchers have developed a magnetic nanomaterial that can kill bone cancer cells and support bone regeneration at the same ...
Gastric cancer cells can activate KRAS-driven signals, enabling autonomous tumor growth by producing their own WNT proteins. New research reveals how gastric cancer cells exploit WNT signaling for ...
A new study reveals how a single cancer protein may simultaneously drive tumor survival and metabolic control, uncovering a ...
Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.
A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...
The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...
The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback